8.5-8.11 | 临床研究顶刊快报
文摘
教育
2024-08-12 10:08
中国香港
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
1. Sarafoglou, K., et al., Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia. New England Journal of Medicine, 2024. 391(6): p. 493-503.2. Auchus, R.J., et al., Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia. New England Journal of Medicine, 2024. 391(6): p. 504-514.3. Xie, Y., T. Choi, and Z. Al-Aly, Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras. New England Journal of Medicine, 2024. 391(6): p. 515-525.4. Moise, K.J., et al., Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn. New England Journal of Medicine, 2024. 391(6): p. 526-537.5. Raghu, G., et al., Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial. JAMA, 2024. 332(5): p. 380-389.6. Ware, L.B., et al., Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial. JAMA, 2024. 332(5): p. 390-400.7. Tavares, C.A.M., et al., Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial. JAMA, 2024. 332(5): p. 401-411.8. Krämer, A., et al., Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study. The Lancet, 2024. 404(10452): p. 527-539.9. Fisher, B.A., et al., Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study. The Lancet, 2024. 404(10452): p. 540-553.10. Joundi, R.A., et al., Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study. The Lancet, 2024. 404(10452): p. 554-569.11. Lara-Castor, L., et al., Intake of sugar sweetened beverages among children and adolescents in 185 countries between 1990 and 2018: population based study. BMJ, 2024. 386: p. e079234. 12. Kgomotso, E.L., et al., Decompression alone or with fusion for degenerative lumbar spondylolisthesis (Nordsten-DS): five year follow-up of a randomised, multicentre, non-inferiority trial. BMJ, 2024. 386: p. e079771.部分文字参考新英格兰医学前沿。
